Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The vascular disruption pathway refers to a series of molecular and cellular events that lead to the impairment or destruction of blood vessel integrity, function, or development. This pathway is particularly significant in embryonic development (where it can cause adverse outcomes) and in pathological conditions such as cancer, trauma, and certain toxic exposures. Key components include VEGF/VEGFR signaling, integrin signaling, and other pathways regulating endothelial cell survival, adhesion, and permeability. Disruption of this pathway can result in malformations, tumor necrosis, and other disease-related effects.
N/A
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Vascular Disruption Pathway (N/A).